243 related articles for article (PubMed ID: 22683420)
1. Future directions and treatment strategies for head and neck squamous cell carcinomas.
Wise-Draper TM; Draper DJ; Gutkind JS; Molinolo AA; Wikenheiser-Brokamp KA; Wells SI
Transl Res; 2012 Sep; 160(3):167-77. PubMed ID: 22683420
[TBL] [Abstract][Full Text] [Related]
2. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
Bzhalava Z; Arroyo Mühr LS; Dillner J
Vaccine; 2020 May; 38(25):4066-4070. PubMed ID: 32362526
[TBL] [Abstract][Full Text] [Related]
3. Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck.
Psyrri A; Sasaki C; Vassilakopoulou M; Dimitriadis G; Rampias T
Head Neck Pathol; 2012 Jul; 6 Suppl 1(Suppl 1):S121-8. PubMed ID: 22782231
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.
Cooper T; Biron VL; Fast D; Tam R; Carey T; Shmulevitz M; Seikaly H
J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):8. PubMed ID: 25890191
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.
LaRocca CJ; Han J; Salzwedel AO; Davydova J; Herzberg MC; Gopalakrishnan R; Yamamoto M
Oral Oncol; 2016 May; 56():25-31. PubMed ID: 27086483
[TBL] [Abstract][Full Text] [Related]
6. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
7. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
8. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for head and neck cancer patients: shifting the balance.
Turksma AW; Braakhuis BJ; Bloemena E; Meijer CJ; Leemans CR; Hooijberg E
Immunotherapy; 2013 Jan; 5(1):49-61. PubMed ID: 23256798
[TBL] [Abstract][Full Text] [Related]
10. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.
Kong CS; Narasimhan B; Cao H; Kwok S; Erickson JP; Koong A; Pourmand N; Le QT
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):553-61. PubMed ID: 19427557
[TBL] [Abstract][Full Text] [Related]
11. Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: Improved effectiveness of cisplatin in HPV-positive tumors.
Prevc A; Niksic Zakelj M; Kranjc S; Cemazar M; Scancar J; Kosjek T; Strojan P; Sersa G
Bioelectrochemistry; 2018 Oct; 123():248-254. PubMed ID: 29898433
[TBL] [Abstract][Full Text] [Related]
12. Molecular targeted therapies in all histologies of head and neck cancers: an update.
Razak AR; Siu LL; Le Tourneau C
Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
[TBL] [Abstract][Full Text] [Related]
13. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
14. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
15. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
16. The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.
Pryor DI; Solomon B; Porceddu SV
Asia Pac J Clin Oncol; 2011 Sep; 7(3):236-51. PubMed ID: 21884435
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression Characterization of HPV Positive Head and Neck Cancer to Predict Response to Chemoradiation.
Thibodeau BJ; Geddes TJ; Fortier LE; Ahmed S; Pruetz BL; Wobb J; Chen P; Wilson GD; Akervall JA
Head Neck Pathol; 2015 Sep; 9(3):345-53. PubMed ID: 25481760
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
[TBL] [Abstract][Full Text] [Related]
19. Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer.
Whang SN; Filippova M; Duerksen-Hughes P
Viruses; 2015 Sep; 7(9):5040-65. PubMed ID: 26393639
[TBL] [Abstract][Full Text] [Related]
20. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]